Copyright © 2026 GALAXIS TECHNOLOGY. All rights reserved.
From Intralogistics Robotics to Industrial Embodied Intelligence
Since its establishment, the company has always strictly followed the relevant laws and regulations as well as the rules, regulations and normative documents issued by the regulatory authorities, to establish and improve the internal management and control systems of the company, promote its standardized operation, and safeguard the legitimate rights and interests of the company.
Chair person of the Board, executive Director and chief executive officer
Executive Director and vice president
Executive Director and vice president
Executive Director and vice president
Mr. LI Qiuyu has served as a non-executive Director since June 2019, responsible for overseeing Board affairs and providing strategic advice on the Group’s business operations.
Mr. SHEN Qi has served as a non-executive Director since June 2025, responsible for overseeing Board affairs and providing strategic advice on the Group’s business operations.
Served as an independent non-executive Director since June 2025 (initially appointed as an independent director in July 2021), responsible for providing independent advice and judgment to the Board.
Served as an independent non-executive Director since June 2025, responsible for providing independent advice to the Board on financial management and accounting practices.
Served as an independent non-executive Director since June 2025 (initially appointed as an independent director in July 2021), responsible for providing independent advice and judgment to the Board.
Responsible for leading the Group’s strategic planning, business direction and overall management; Tenure as Director: since October 15, 2016.
Responsible for brand management, public relations oversight, industrial development planning and external strategic cooperation; Tenure as Director: since October 15, 2018.
Responsible for business development and market expansion; Tenure as Director: since November 15, 2016.
Responsible for leading the Group’s AI Research Institute and driving research, development and application in intelligent logistics; Tenure as Senior Management: since October 1, 2018.
Responsible for financial management, board affairs and capital operation related work; Tenure as Senior Management: since January 13, 2025.
Responsible for overall business operation and human resource management; Tenure as Senior Management: since November 30, 2017.
Our Company has established four committees under the Board in accordance with the relevant laws and regulations in mainland China, the Articles and the code of corporate governance practices under the Listing Rules, including the Audit Committee, the Remuneration and Appraisal Committee, the Nomination Committee and the Strategy Committee.
We have established an Audit Committee in compliance with Rule 3.21 of the Listing Rules and the Corporate Governance Code set out in Appendix C1 to the Listing Rules. The primary duties of the Audit Committee are to (i) assisting our Board by providing an independent view of the effectiveness of the financial reporting process, internal control and risk management systems of our Group, (ii) overseeing the audit process, and (iii) performing other duties and responsibilities as assigned by our Board. TheAudit Committee comprises one non-executive Director, namely Mr. SHEN Qi and two independent non-executive Directors, namely, Mr. LAU Hak Lap and Mr. MO Rong. Mr. LAU Hak Lap is the chairperson of the Audit Committee. Mr. LAU holds the appropriate professional qualifications as required under Rules 3.10(2) and 3.21 of the Listing Rules.
We have established a Remuneration and Appraisal Committee in compliance with Rule 3.25 of the Listing Rules and the Corporate Governance Code set out in Appendix C1 to the Listing Rules. The primary duties of the Remuneration and Appraisal Committee are to (i) making recommendations to our Board on our policy and structure for all remuneration of Directors and senior management and on the establishment of a formal and transparent procedure for developing policy on such remuneration; (ii) determining the specific remuneration packages of all Directors and senior management; and (iii) reviewing and approving remuneration proposals in accordance with the corporate policies and objectives resolved by our Board. The Remuneration and Appraisal Committee comprises one executive Director, namely, Dr. BAI Hongxing, and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. MO Rong. Mr. HU Jianqiang is the chairperson of the Remuneration and Appraisal Committee.
We have established a Nomination Committee in compliance with the Code on Corporate Governance set out in Appendix C1 to the Listing Rules. The primary duties of the Nomination Committee are to (i) reviewing the structure, size and composition of our Board, (ii) assessing the independence of independent non-executive Directors and (iii) making recommendations to our Board on matters relating to the appointment of Directors. The Nomination Committee comprises one executive Director, namely, Dr. YANG Yan, and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. LAU Hak Lap. Dr. HU Jianqiang is the chairperson of the Nomination Committee.
We have established the Strategy Committee in compliance with the Article of Association. The primary duties of the Strategy Committee are to make recommendations to our Board on the long-term development strategy and major investments and projects of our Company. The Strategy Committee comprises one executive Director, namely, Dr. GU Chunguang and two independent non-executive Directors, namely, Dr. HU Jianqiang and Mr. MO Rong. Dr. GU Chunguang is the chairperson of the Strategy Committee.
IR Department
1118 Chicheng Road, Daqiao Town, Nanhu District, Jiaxing City, Zhejiang Province, China
Chair person of the Board, executive Director and chief executive officer
Dr. GU Chunguang, is our founder, chairperson of the Board, an executive Director and the chief executive officer of our Company. He was appointed as a Director in October 2016 and redesignated as an executive Director in June 2025. Dr. GU also holds directorships or supervisorships across all of five major subsidiaries namely Galaxis Wuxi, Hubei Galaxis Tongda Technology, Zhejiang Galaxis International Trade, Guangdong Galaxis Jiadi and Anhui Galaxis. He is mainly responsible for leading the strategic planning, business direction and overall management of our Group.
Dr. GU has over 25 years of experience in the fields of supply chain management, logistics systems, and advanced logistics equipment technology. Before founding our Group, Dr. GU started his career at i2 Technologies in the United States from August 1999. Dr. GU worked at McKinsey & Consulting Company Inc., Shanghai from March 2005 to June 2008, with his last position as engagement manager. From February 2008 to November 2017, he served as the chief technology officer at Jointown Pharmaceutical Group Co., Ltd. (“Jointown Pharmaceutical”), a company listed on the Shanghai Stock Exchange (stock code: 600998).
Dr. GU obtained a bachelor’s degree in engineering from Tsinghua University in the PRC in July 1993 and a Ph.D. in mechanical engineering from the Massachusetts Institute of Technology in the United States in February 2000. Besides, Dr. GU was qualified as a professor-level senior engineer by the Department of Human Resources and Social Security of Zhejiang Province in June 2020.
In recognition of his outstanding contributions to the logistics and modern service field, Dr. GU was honored as a National Model Worker in the logistics industry by Ministry of Human Resources and Social Security and China Federation of Logistics & Purchasing, and one of China’s Top Ten Contributors to the Logistics Industry by China International Logistics Technology and Services Exhibition Committee and Modern Logistics News.
Executive Director and vice president
Dr. YANG Yan, is our executive Director and vice president. She was initially serving as a Director in October 2016, reappointed since October 2018 and redesignated as an executive Director in June 2025. Dr. YANG’s retirement from the Board in 2016 was a planned adjustment to accommodate new investor representative Directors and maintain an odd-numbered Board for effective governance. Throughout 2016 to 2018, she continued to serve our Group as a deputy general manager, responsible for investment, financing and Board affairs. Following a subsequent adjustment to the Board’s structure, she was reappointed as a Director in 2018, a move that maintained the Board to an odd number of members and retained her executive experience at the Board level.
She is mainly responsible for brand management and overseeing public relations, industrial development planning and external strategic cooperation matters. Dr. YANG has extensive experience in electrical and electronic engineering, as well as in managing technology-driven entrepreneurial ventures.
Dr. YANG was with Aware Inc. in the United States as a digital signal processing engineer from October 1999, before she joined Infineon Technologies (China) Co., Ltd (“Infineon China”) in May 2006. At Infineon China, she served as a senior staff engineer until January 2010. Dr. YANG worked at Lantiq (Shanghai) Communications Technology Co., Ltd from January 2010 to November 2012, a period during which she undertook as a principal engineer.
Dr. YANG obtained a bachelor’s degree in electronic engineering from Tsinghua University in the PRC in July 1993, and a Ph.D. in electrical engineering from Cornell University in the United States in January 2000. Dr. YANG has published multiple technical papers in leading journals of the Institute of Electrical and Electronics Engineers (IEEE) and holds over 70 patents.
The research, development and application of advanced logistics equipment and robotics under her leadership was selected as a Leading Talent Entrepreneurial Project by the Administrative Committee of Wuxi National High-tech Industrial Development Zone. In recognition of her pioneering work in logistics and modern service field, Dr. YANG was recognized as a Leading Entrepreneurial Talent in emerging industry of Wuxi by Wuxi Science and Technology Bureau, and honored with the Technology Innovation Award by the Jiaxing Women Entrepreneurs Association.
Executive Director and vice president
Mr. SHEN Lu, is our executive Director and vice president. He joined our Group as the vice president in August 2014, and then was appointed as a Director in October 2016 and redesignated as an executive Director in June 2025. Mr. SHEN also holds directorship in Galaxis Wuxi. He is mainly responsible for business development and market expansion.
Mr. SHEN has extensive experience in product development and marketing management particularly in the logistics and automation industries.
Before joining our Group, from August 1993 to December 1998, Mr. SHEN was with COSCO Container Lines Co., Ltd. He then served at ChinaStar International Economic and Technical Cooperation Co., Ltd. fromMarch 1999 to March 2000. FromApril 2000 to January 2005, he worked in Kesai Logistics System Equipment (Shanghai) Co., Ltd. From November 2007 to June 2014, he was the general manager at Galaxy Automotion Management GmbH.
Mr. SHEN obtained a bachelor’s degree in marine electrical management from Shanghai Maritime University in the PRC in July 1993.
Executive Director and vice president
Dr. BAI Hongxing, is our executive Director and vice president. He joined our Group as a vice president in October 2018, and then was appointed as an executive Director in June 2025. He is primarily responsible for leading the AI research institute of the Group and driving research, development, and application in the field of intelligent logistics. Dr. BAI has extensive experience in technology innovation, logistics intelligence, and corporate management.
From 2008 to 2015, Dr. BAI was with Jointown Pharmaceutical and held several positions including (i) as a supervisor, (ii) as a deputy manager of logistic management department, and (iii) as the general manager at Jointown Chinese herbal medicine electronic commerce Co., Ltd. Dr. BAI founded Wuhan Gooding Health Technology Co., Ltd., where he served as an executive director and a manager from April 2015 to July 2024.
Dr. BAI obtained a bachelor’s degree in automation and a Ph.D. in control science and engineering from Tsinghua University in the PRC in July 2003 and in July 2008, respectively.
Dr. BAI has received multiple honors for his contributions to technology and logistics innovation. In 2012, he was selected for the “Hanyang Talent Plan”by the CPC Hanyang District Committee. In 2013, he was honored as one of the “Top Ten Outstanding Innovative Individuals Influencing Suining by the Suining Municipal Government. In 2014, he received the “Science and Technology Progress Award (Innovative Individuals)”from the China Federation of Logistics & Purchasing. In 2017, he was selected for the “Qiaokou Talent Plan” by the CPC Qiaokou District Committee.
Contact our experts to discover the right automation solution for your business.